发明名称 ANTIDIABETIC COMPOUNDS
摘要 Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.
申请公布号 US2016332968(A1) 申请公布日期 2016.11.17
申请号 US201515110894 申请日期 2015.02.03
申请人 CHOBANIAN Harry;DEMONG Duane;Guo Yan;Hu Zhiyong;PIO Barbara;PLUMMER Christopher;XIAO Dong;YANG Cangming;ZHANG Rui;Merck Sharp & Dohme Corp. ;Michael MILLER 发明人 Chobanian Harry;DeMong Duane;Guo Yan;Hu Zhiyong;Miller Michael;Pio Barbara;Plummer Christopher W.;Xiao Dong;Yang Michael
分类号 C07D211/42;C07D211/22;C07D205/04;C07D209/54;C07D209/52;C07D207/12;C07D205/12;C07C217/52;C07D401/04;C07D265/30;C07C59/72;C07D213/64;C07D213/69;C07D239/52;C07D231/20;C07D307/88;C07D491/056;C07D307/86;C07D213/30;C07D213/647;C07D207/08 主分类号 C07D211/42
代理机构 代理人
主权项 1. A compound of structural formula I: or a pharmaceutically acceptable salt thereof; wherein A is selected from the group consisting of: (1) —C3-9cycloalkyl,(2) —C3-9cycloalkenyl,(3) —C2-10cycloheteroalkyl, and(4) —C2-10cycloheteroalkenyl, wherein each cycloalkyl, cycloalkenyl, cycloheteroalkyl and cycloheteroalkenyl is unsubstituted or substituted with one, two or three substituents selected from Ra; B is selected from the group consisting of: (1) —(CH2)u-aryl,(2) —(CH2)u-heteroaryl,(3) —(CH2)u-aryl-aryl,(4) —(CH2)u—N(Rg)—(CH2)u-aryl,(5) —(CH2)u—N(Rg)—(CH2)u-heteroaryl,(6) —(CH2)u—O—(CH2)u-aryl,(7) —(CH2)u—O—(CH2)u-aryl-aryl,(8) —(CH2)u—O—(CH2)u-heteroaryl,(9) —(CH2)u—C3-6cycloalkyl,(10) —(CH2)u—O—(CH2)u—C3-6cycloalkyl,(11) —(CH2)u—C2-6cycloheteroalkyl, and(12) —(CH2)u—O—(CH2)u—C2-6cycloheteroalkyl, wherein each CH2, cycloalkyl, cycloheteroalkyl, aryl and heteroaryl is unsubstituted or substituted with one, two, three, four or five substituents selected from Rb; T is selected from the group consisting of: (1) CH,(2) N, and(3) N-oxide; U is selected from the group consisting of: (1) CH,(2) N, and(3) N-oxide; V is selected from the group consisting of: (1) CH,(2) N, and(3) N-oxide; W is selected from the group consisting of: (1) CH,(2) N, and(3) N-oxide, provided that no more than three of T, U, V and W are selected from N and N-oxide; Y is selected from the group consisting of: (1) —(CH2)xO—,(2) —O—(CH2)x,(3) —(CH2)x—NRf—,(4) —(CH2)x—S—,(5) —(CH2)x—CH2—,(6) —(CH2)x—C(O)—,(7) —(CH2)x—CF2—, and(8) —CF2—(CH2)x—, wherein CH2 is unsubstituted or substituted with one or two substituents selected from Ri; Z is selected from the group consisting of: (1) —C0-6alkyl-CO2H,(2) —C0-6alkyl-CO2Rj,(3) —C0-6alkyl-C(O)NHRh,(4) —C0-6alkyl-C(O)NHSO2Rh,(5) —C0-6alkyl-SO2NHC(O)Rh,(6) —C0-6alkyl-heteroaryl, and(7) —C0-6alkyl-cycloheteroalkyl, wherein cycloheteroalkyl is selected from the group consisting of: wherein each alkyl, cycloheteroalkyl and heteroaryl is unsubstituted or substituted with one to five substituents selected from C1-6alkyl; each R1 is independently selected from the group consisting of: (1) hydrogen,(2) halogen,(3) —(CH2)s—OC1-6alkyl,(4) —(CH2)s—OH,(5) —CN, and(6) —C1-6alkyl, wherein CH2 and alkyl are unsubstituted or substituted with one, two or three halogens; each R2 is independently selected from the group consisting of: (1) hydrogen,(2) —(CH2)s—O—C1-6alkyl,(3) —C1-6alkyl,(4) —C3-6cycloalkyl, and(5) —C2-4cycloheteroalkyl, wherein each CH2, alkyl, cycloalkyl and cycloheteroalkyl is unsubstituted or substituted with one, two or three substituents selected from halogen, OH, —C1-6alkyl and —OC1-6alkyl; each R3 is independently selected from the group consisting of: (1) hydrogen,(2) halogen,(3) —(CH2)s—OC1-6alkyl,(4) —(CH2)s—OH,(5) —CN, and(6) —C1-6alkyl, wherein CH2 and alkyl are unsubstituted or substituted with one, two or three substituents selected from halogen, OH, and OC1-6alkyl; each Ra is independently selected from the group consisting of: (1) —C1-6alkyl,(2) halogen,(3) —(CH2)u—OC1-6alkyl,(4) —ORe,(5) —S(O)uRe,(6) —S(O)uNRcRd,(7) —N(Rc)S(O)pRe,(8) —NRcRd,(9) —C(O)Re,(10) —OC(O)Re,(11) —CO2Re,(12) —N(Rc)C(O)Re,(13) —N(Rc)C(O)ORe,(14) —N(Rc)C(O)NRcRd,(15) —C(O)NRcRd,(16) —CN,(17) —CF3,(18) —OCF3,(19) —OCHF2,(20) —(CH2)raryl,(21) —(CH2)rheteroaryl,(22) —(CH2)r—C3-6cycloalkyl,(23) —(CH2)r—C3-6cycloalkenyl,(24) —(CH2)r—C2-5cycloheteroalkyl, and(25) —(CH2)r—O—(CH2)r—C3-6cycloalkyl, wherein each CH2, alkyl, cycloalkyl, cycloalkenyl, cycloheteroalkyl, aryl and heteroaryl is unsubstituted or substituted with one to four substituents selected from: halogen, —C1-6alkyl, —(CH2)w—OH, —O—C1-6alkyl, —CF3, —CN, —(CH2)v—C3-6cycloalkyl, SH, and —SO2—C1-6alkyl; each Rb is independently selected from the group consisting of: (1) —C1-10alkyl,(2) —C2-10alkenyl,(3) —(CH2)v—CF3,(4) —O(CH2)vCF3,(5) —OCHF2,(6) —S(CH2)vCF3,(7) —(CH2)vSC1-10alkyl,(8) halogen,(9) oxo,(10) —(CH2)vCN,(11) —(CH2)vOH(12) —(CH2)vOC1-10alkyl,(13) —(CH2)vOC2-10alkenyl,(14) —O—(CH2)vOC1-10alkyl,(15) —(CH2)v—O—(CH2)vC3-6cycloalkyl,(16) —(CH2)v—O—(CH2)vC2-10cycloheteroalkyl,(17) —(CH2)v—O—(CH2)v-aryl,(18) —(CH2)v—O—(CH2)v-heteroaryl,(19) —(CH2)v O(CH2)vN(Rc)S(O)qRe,(20) —(CH2)v O(CH2)vS(O)qRe,(21) —(CH2)v O(CH2)vS(O)qNRcRd,(22) —(CH2)v O(CH2)vNRcRd,(23) —C(O)Re,(24) —OC(O)Re,(25) —CO2Re,(26) —C(O)NRcRd,(27) —N(Rc)C(O)Re,(28) —N(Rc)C(O)ORe,(29) —N(Rc)C(O)NRcRd,(30) —N(Rc)S(O)qRe,(31) —S(O)qRe,(32) —S(O)qNRcRd,(33) —NRcRd,(34) —O(CH2)vO—C3-6cycloalkyl,(35) —O(CH2)vO—C2-5cycloheteroalkyl,(36) —O(CH2)vO-aryl,(37) —O(CH2)vO-heteroaryl,(38) —(CH2)vC3-6cycloalkyl,(39) —(CH2)vC2-10cycloheteroalkyl,(40) —(CH2)v-aryl, and(41) —(CH2)v-heteroaryl, wherein each CH, CH2, alkyl, alkenyl, cycloalkyl, cycloheteroalkyl, aryl and heteroaryl is unsubstituted or substituted with one, two or three substituents selected from: halogen, —C1-6alkyl, —(CH2)w—OH, —O—C1-6alkyl, —CF3, —CN, —(CH2)v—C3-6cycloalkyl, SH, and —SO2—C1-6alkyl; each Rc is independently selected from the group consisting of: (1) hydrogen,(2) C1-10alkyl,(3) C3-6cycloalkyl,(4) C2-5cycloheteroalkyl,(5) aryl, and(6) heteroaryl, wherein each alkyl, cycloalkyl, cycloheteroalkyl, aryl and heteroaryl is unsubstituted or substituted with one to three substituents selected from C1-6alkyl; each Rd is independently selected from the group consisting of: (1) hydrogen,(2) C1-10alkyl,(3) C3-6cycloalkyl,(4) C2-5cycloheteroalkyl,(5) aryl, and(6) heteroaryl, wherein each alkyl, cycloalkyl, cycloheteroalkyl, aryl and heteroaryl is unsubstituted or substituted with one to three substituents selected from C1-6alkyl; each Re is independently selected from the group consisting of: (1) hydrogen,(2) C1-10alkyl,(3) C3-6cycloalkyl,(4) C2-5cycloheteroalkyl,(5) aryl, and(6) heteroaryl, wherein each alkyl, cycloalkyl, cycloheteroalkyl, aryl and heteroaryl is unsubstituted or substituted with one to three substituents selected from C1-6alkyl; each Rf is independently selected from the group consisting of: (1) hydrogen,(2) C1-6alkyl, and(3) C3-6cycloalkyl; each Rg is independently selected from the group consisting of: (1) hydrogen,(2) halogen,(3) C1-6alkyl, and(4) C3-6cycloalkyl; each Rh is independently selected from the group consisting of: (1) hydrogen,(2) —C1-10alkyl,(3) —C2-10 alkenyl,(4) —C3-6 cycloalkyl,(5) C3-6 cycloalkyl-C1-10alkyl-,(6) —C2-5cycloheteroalkyl,(7) C2-5cycloheteroalkyl-C1-10alkyl-,(8) aryl,(9) heteroaryl,(10) aryl-C1-10alkyl-, and(11) heteroaryl-C1-10alkyl-, wherein alkyl, alkenyl, cycloalkyl, cycloheteroalkyl, aryl and heteroaryl are unsubstituted or substituted with one to four substituents selected from C1-6alkyl; each Ri is independently selected from the group consisting of: (1) hydrogen,(2) halogen,(3) —C1-6alkyl,(4) —(CH2)s—O—C1-6alkyl,(5) —(CH2)sOH,(6) —N(Rc)S(O)2Re,(7) —S(C1-6alkyl),(8) —(CH2)sSO2C1-6alkyl,(9) —(CH2)sSO2—(CH2)t—C3-6cycloalkyl,(10) —S(O)2NRcRd,(11) —NRcRd,(12) —C(O)Re,(13) —OC(O)Re,(14) —CO2Re,(15) —(CH2)sCN,(16) —C(O)NRcRd,(17) —N(Rc)C(O)Re,(18) —N(Rc)C(O)ORe,(19) —N(Rc)C(O)NRcRd,(20) —CF3,(21) —OCF3,(22) —OCHF2,(23) —C3-6cycloalkyl, and(24) —C2-5cycloheteroalkyl, wherein each CH2, alkyl, cycloalkyl and cycloheteroalkyl is unsubstituted or substituted with one, two, three or four substituents selected from: —C1-6alkyl and halogen; each Rj is independently selected from the group consisting of: (1) —C1-6alkyl,(2) —C3-6cycloalkyl, and(3) -aryl-C1-6alkyl, wherein each alkyl, cycloalkyl and aryl is unsubstituted or substituted with one to three substituents selected from Rk; each Rk is independently selected from the group consisting of: (1) —C1-6alkyl,(2) —ORe,(3) —N(Rc)S(O)pRe,(4) halogen,(5) —S(O)pRe,(6) —S(O)pNRcRd,(7) —NRcRd,(8) —C(O)Re,(9) —OC(O)Re,(10) —CO2Re,(11) —CN,(12) —C(O)NRcRd,(13) —N(Rc)C(O)Re,(14) —N(Rc)C(O)ORe,(15) —N(Rc)C(O)NRcRd,(16) —CF3,(17) —OCF3,(18) —OCHF2,(19) —C3-6cycloalkyl, and(20) —C2-5cycloheteroalkyl; n is independently selected from: 1 and 2; m is independently selected from: 1 and 2; each p is independently selected from: 0, 1 and 2; each q is independently selected from: 0, 1 and 2; each r is independently selected from: 1, 2, 3 and 4; each s is independently selected from: 0, 1, 2 and 3; each t is independently selected from: 0, 1, 2, 3 and 4; each u is independently selected from: 0, 1, 2 and 3; each v is independently selected from: 0, 1, 2, 3 and 4; each w is independently selected from: 0, 1, 2 and 3; and each x is independently selected from: 0, 1 and 2.
地址 Kenilworth NJ US